Physician profile
James P Bell
NPI 1417945726
$972.95
in general payments reported to CMS, 2019-2025
17 companies · $54.13 in 2025
The $54.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $520 · 2022: $134 · 2023: $80.46 · 2024: $184 · 2025: $54.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $352.91 | 2021-2025 | |
| Novo Nordisk INC | $204.73 | 2021-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $73.63 | 2022-2024 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $69.43 | 2021-2024 | Airsupra |
| Amgen INC. | $48.35 | 2023-2024 | Repatha, Otezla |
| Exact Sciences Corporation | $29.56 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $24.49 | 2022 | |
| Inspire Medical Systems, INC. | $23.53 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $22.41 | 2024 | |
| Avanir Pharmaceuticals, INC. | $19.39 | 2021 | |
| Sanofi Pasteur INC. | $19.04 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.08 | 2024 | |
| Pfizer INC. | $14.62 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.19 | 2021 | |
| Merck Sharp & Dohme LLC | $13.48 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.39 | 2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.